Serotonin

Serotonin

SCHEMBL3091827

NCCc1c[nH]c2ccc(O)cc12.[PbH2]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 7/20 0.97
HTR2A P28223 7/20 0.97
HTR1A P08908 7/20 0.97
HTR1D P28221 6/20 0.97
HTR1B P28222 4/20 0.97
HTR7 P34969 3/20 0.97
HTR2B P41595 2/20 0.97
CYP2D6 P10635 2/20 0.97
CYP1A2 P05177 2/20 0.97
TSHR P16473 2/20 0.97
HTR5A P47898 2/20 0.97
HTR6 P50406 2/20 0.97
HTR3E A5X5Y0 1/20 0.97
HTR3B O95264 1/20 0.97
CYP3A4 P08684 1/20 0.97
CYP2C9 P11712 1/20 0.97
DRD1 P21728 1/20 0.97
HTR1E P28566 1/20 0.97
HTR1F P30939 1/20 0.97
DRD3 P35462 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serotonin SCHEMBL30057954 0.98 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL29349412 0.98 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL1495 0.98 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL183226 0.98 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL25341783 0.97 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL8208967 0.97 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL29669289 0.97 HTR2C (0.97) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL29781387 0.97 HTR2C (1.00) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL396997 0.97 HTR2C (0.97) HTR2CHTR2AHTR1AHTR1DHTR1B
Serotonin SCHEMBL1675866 0.97 HTR2C (0.97) HTR2CHTR2AHTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106456673-A Enamel products and methods of use 纽约州立大学研究基金会 2017-02-22 CN disclosed
US-8084497-B2 C-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia GRUENENTHAL GMBH (DE) 2011-12-27 US disclosed
US-20100249225-A1 C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for the Treatment of Anxiety Disorders GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100004341-A1 C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for Therapy of Fibromyalgia GRUENENTHAL GMBH (DE) 2010-01-07 US disclosed
US-20060258741-A1 C-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders GRUENENTHAL GMBH 2006-11-16 US disclosed
WO-2006063164-A2 COMPOSITIONS AND METHODS FOR TREATING NEUROENDOCRINE TUMORS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2006-06-15 WO disclosed
US-20060121040-A1 Compositions and methods for treating neuroendocrine tumors WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258741-A1 C-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders PNMT, HTR2C, HTR2A HTR2C 2/4885HTR2A 3/4885HTR1A 8/4885
US-20100004341-A1 C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for Therapy of Fibromyalgia PNMT, HNMT, GNMT HTR2C 11/4885HTR2A 13/4885HTR1A 47/4885
US-20100249225-A1 C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for the Treatment of Anxiety Disorders PNMT, HTR2C, HTR2A HTR2C 2/4885HTR2A 3/4885HTR1A 8/4885
US-20060121040-A1 Compositions and methods for treating neuroendocrine tumors GSK3B, GSK3A, NEK3 HTR2C 646/4885HTR2A 817/4885HTR1A 409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.